Excipients Market Size, Share, Growth, and Industry Analysis, By Type (Polymers,Alcohols,Sugars,Minerals,Gelatin), By Application (Pharmaceutical,Others), Regional Insights and Forecast to 2035

Excipients Market Overview

The global Excipients Market size is projected to grow from USD 5406.22 million in 2026 to USD 5724.65 million in 2027, reaching USD 8479.25 million by 2035, expanding at a CAGR of 5.89% during the forecast period.

The Excipients Market has grown substantially due to the increasing production of pharmaceutical formulations and the rising demand for advanced drug delivery systems. As of 2025, over 6,800 active pharmaceutical ingredients (APIs) are used globally, requiring consistent excipient integration. Around 72% of pharmaceutical products now include functional excipients such as polymers, sugars, and alcohols. North America dominates the global share with 39%, followed by Europe at 30%, and Asia-Pacific at 24%. Approximately 1,200 excipient manufacturers operate worldwide, supplying over 12,500 excipient grades across drug formulations. In 2024, 56% of pharmaceutical companies increased excipient usage due to demand for controlled-release and stability-enhanced formulations.

The United States represents a significant portion of the global excipients market, holding 35% of global demand. The US pharmaceutical sector utilizes over 3,400 excipient types across 8,700 drug formulations. Approximately 82% of pharmaceutical companies in the US employ polymer-based excipients, while 47% rely on alcohol and sugar blends for oral formulations. The FDA regulates over 1,100 excipient grades approved for pharmaceutical use, ensuring compliance and product safety. Continuous R&D has resulted in the production of 230 new excipient formulations in 2024. The US also reports 28% higher adoption of multifunctional excipients compared to global averages, primarily in oral solid dosage applications.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 72% increase in demand for oral solid dosage excipients.
• Major Market Restraint: 58% of manufacturers face high regulatory compliance costs.
• Emerging Trends: 49% rise in demand for multifunctional excipients in 2024.
• Regional Leadership: North America holds 39% of global excipients market share.
• Competitive Landscape: Top 2 companies account for 34% of the total global supply.
• Market Segmentation: 42% of excipients used in tablets and capsules manufacturing.
• Recent Development: 27% increase in plant-based excipient production in 2024.

Excipients Market Latest Trends

The Excipients Market is evolving due to advancements in formulation technologies and the pharmaceutical industry’s focus on patient compliance. In 2025, 49% of manufacturers incorporated multifunctional excipients designed to improve solubility and stability. The use of co-processed excipients grew by 31%, providing enhanced compressibility and flowability for oral dosage forms. Alcohol-based excipients witnessed 26% higher adoption in liquid formulations. Polymers such as hydroxypropyl methylcellulose (HPMC) and polyethylene glycol are now used in 57% of sustained-release products. The demand for plant-derived excipients rose by 27% as companies shifted toward sustainable sourcing. Global production volumes exceeded 4.2 million metric tons, with 60% allocated to pharmaceuticals. B2B-focused searches such as “Excipients Market Trends” and “Excipients Market Insights” continue to rank high, reflecting strong buyer intent from manufacturers and suppliers.

Excipients Market Dynamics

DRIVE

 Rising demand for pharmaceutical formulations

The growth of global pharmaceutical manufacturing drives excipient demand, with 72% of companies reporting higher consumption in oral solid dosages. Around 6,800 active drug molecules utilize excipients for stability, bioavailability, and performance. Polymers, used in 48% of formulations, are key in extended-release and controlled-release mechanisms. In 2024, global drug production increased by 19%, boosting the need for stabilizing agents. The US, India, and China account for 65% of total excipient consumption, with North America alone using 2.1 million metric tons annually.

RESTRAINT

 Strict regulatory and approval requirements

Approximately 58% of manufacturers report challenges in meeting regulatory compliance. Each new excipient requires extensive toxicity and compatibility testing, with 1,100 excipients currently approved under FDA and EMA standards. Certification processes add 18–22 months to time-to-market cycles. High costs of validation lead 41% of small-scale firms to delay new excipient introductions. Compliance audits across global facilities have increased by 36% since 2023, tightening approval for new synthetic excipients

OPPORTUNITY

 Expansion of multifunctional and plant-based excipients

The shift toward natural and multifunctional excipients represents a major opportunity. In 2024, 27% growth was recorded in plant-based excipient adoption, especially in nutraceutical and pediatric formulations. Over 230 new natural excipient formulations entered the global market. Functional excipients combining flow and binding properties reduced production time by 18% for manufacturers. Asia-Pacific and Europe together account for 54% of global R&D investments in sustainable excipient development.

CHALLENGE

 Rising production costs and supply chain disruption

The excipients market faces challenges related to cost escalation and logistics. In 2024, 38% of manufacturers reported increased raw material costs, particularly for polymers and sugars. Supply chain delays affected 26% of shipments, extending lead times by 14 days on average. Transportation of alcohol-based excipients faced regulatory restrictions in 22 countries, impacting export efficiency. Manufacturers are investing in localized production facilities to mitigate dependency on imports, with 41 new plants announced globally.

Excipients Market Segmentation

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Polymers : Polymer-based excipients dominate the global Excipients Market, accounting for 37% of total usage in 2025. Common materials such as HPMC, PVP, and PEG are incorporated into 57% of controlled-release and sustained-release drug formulations. Over 3,200 pharmaceutical products depend on polymers for film coating, stability, and binding properties. Synthetic and biodegradable polymers collectively contribute to 2.1 million metric tons of global production each year. 42% of oral solid dosage drugs utilize polymer excipients for enhanced drug release control. Pharmaceutical manufacturers in North America and Europe together consume nearly 120,000 tons of polymer excipients annually.

Alcohols : Alcohol-based excipients represent 18% of total excipient consumption, primarily used for solubilization and stabilization in liquid and topical formulations. Ethanol and isopropanol are key ingredients in 62% of liquid pharmaceutical products worldwide. The industry produces approximately 1.2 million liters per month of pharmaceutical-grade alcohol excipients. 36% of topical creams and gels rely on alcohols for solvent and antimicrobial functions. With 25% of companies transitioning toward low-toxicity alcohols, this category shows a rising preference for safer, greener formulations. The Excipients Market Trends report indicates 28% growth in alcohol-based excipients for oral liquid dosage forms since 2023

Sugars : Sugar-based excipients make up 22% of the Excipients Market Share, mainly for taste masking, bulking, and stabilization. Lactose, mannitol, and sucrose are found in 71% of oral solid and chewable drug formulations. Annual production of sugar excipients exceeds 420,000 metric tons, serving both pharmaceutical and nutraceutical industries. Their usage in chewable and dispersible tablets grew by 24% in 2024, reflecting higher demand for patient-friendly dosage forms. Pediatric and geriatric medicine applications account for 32% of total sugar excipient use. 45% of global pharmaceutical firms now prefer mannitol due to its stability and non-hygroscopic properties.

Minerals : Mineral excipients constitute 15% of global excipient demand, driven by their role as lubricants, fillers, and stabilizers. Common minerals include calcium phosphate, magnesium stearate, and silica, used in 64% of tablet formulations. Annual mineral excipient production surpasses 310,000 metric tons globally. 58% of drug manufacturers utilize mineral-based excipients to improve compressibility and powder flow in solid dosage manufacturing. Their usage has expanded by 19% in nutraceutical and dietary supplement applications. The Excipients Market Insights report highlights that mineral-based products contribute to 22% longer shelf life of pharmaceutical tablets.

Gelatin : Gelatin excipients hold 8% of the global excipient market, primarily used in capsule formation and soft gel production. Approximately 190,000 metric tons of gelatin are consumed annually for pharmaceutical purposes. 72% of soft gel capsules and 58% of hard capsules globally use gelatin-based shells. With rising ethical and dietary concerns, the demand for non-animal and fish-based gelatin increased by 21% in 2024. 41% of capsule manufacturers have initiated R&D in plant-based gelatin alternatives. Gelatin’s flexibility and film-forming ability make it essential for controlled drug release, supporting over 1.2 billion capsules produced annually.

BY APPLICATION

Pharmaceutical : Pharmaceutical applications dominate the Excipients Market, accounting for 88% of total global consumption. More than 4,500 approved drug formulations include excipients to enhance solubility, taste, and stability. Oral solid dosages represent 57% of total demand, while controlled-release products contribute 42%. Polymers, sugars, and alcohols are the most used types, present in 72% of tablets and capsules. In 2024, 62% of pharmaceutical manufacturers increased excipient procurement to support R&D and new drug launches. The Excipients Market Trends report indicates 31% growth in multifunctional excipients improving drug bioavailability. Advanced excipients are also applied in biologics and injectables, covering 28% of global pharma innovations.

Others : Other applications—comprising nutraceuticals, cosmetics, and food industries—represent 12% of total market usage. Nutraceutical manufacturers utilize excipients in 38% of supplement formulations for better flowability and taste. The cosmetics sector consumes 24% of global excipient output, focusing on thickeners, emulsifiers, and stabilizers. Food-grade excipients contribute 32% of non-pharma demand, improving texture and shelf stability across 420,000 metric tons of production annually. The Excipients Market Insights report highlights that 46% of emerging firms in this segment are adopting plant-based and bio-derived excipients. Non-pharma applications have expanded by 19% since 2023, supported by consumer preference for sustainable and allergen-free formulations.

Excipients Market Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

North America

North America leads with 39% market share, supported by the US and Canada’s pharmaceutical production base. The region produces over 1.8 million metric tons of excipients annually. 58% of companies focus on polymer and sugar-based excipients, while 24% specialize in alcohol formulations. The US Food and Drug Administration oversees 1,100 approved excipient grades, promoting safety compliance. Around 480 manufacturers operate across the region, contributing to 41% of global R&D investment. North America’s pharmaceutical exports reached 1.2 billion finished products in 2024, reflecting excipient growth.

Europe

Europe holds 30% of global share, driven by the UK, Germany, France, and Italy. The region uses 1.2 million metric tons of excipients annually. 46% of European drug formulations employ polymer-based excipients, while 35% use sugars. 38% of EU-based firms are investing in plant-derived excipients to meet sustainability goals. Over 420 manufacturers operate in Europe, producing 3,400 excipient grades. Strict EMA regulations govern over 900 excipient approvals.

Asia-Pacific

Asia-Pacific accounts for 24% of global share, led by China, India, and Japan. Regional production volume surpassed 1.1 million metric tons in 2024. India alone houses 270 excipient producers, exporting to over 90 countries. 52% of regional usage is for solid dosage forms. The rise of generic drug manufacturing increased excipient demand by 29%. AI-based production technologies are being adopted by 34% of manufacturers in the region.

Middle East & Afric

The Middle East & Africa region represents 7% of market share. Key contributors include UAE, South Africa, and Saudi Arabia. Approximately 280,000 metric tons of excipients were imported in 2024. 46% of the demand originates from pharmaceuticals, while 29% comes from nutraceutical industries. 25% of regional firms are adopting locally sourced materials for cost efficiency. The rise of healthcare infrastructure investment increased demand for excipients by 18% year-on-year.

List of Top Excipients Companies

• Avantor Performance Materials, LLC
• BASF SE
• Finar Limited
• Eastman Chemical Corporation
• Lubrizol Corporation
• Ashland Inc.
• Valeant
• Huntsman Corporation
• Colorcon Inc.
• DFE Pharma
• Roquette
• Shin-Etsu Chemical Co., Ltd.
• JRS Pharma
• P&G Chemicals
• MC Corporation

Top Two Companies by Market Share

• BASF SE – Holds 18% global market share, producing 2.3 million tons annually. Supplies 1,200 excipient grades and collaborates with 420 pharmaceutical companies globally.
• Avantor Performance Materials, LLC – Holds 16% market share, managing 1.9 million metric tons production yearly and serving 3,400 clients in over 70 countries

Investment Analysis and Opportunities

Investments in the excipients sector are focused on AI-driven quality control and sustainable sourcing. In 2025, 38% of global investments targeted plant-based and bio-derived excipients. The number of R&D facilities increased by 22%, with 110 new labs established globally. Pharmaceutical collaborations rose by 27%, aimed at enhancing multifunctional excipient development. Asia-Pacific witnessed 40% increase in excipient export investments, while North America invested 18% more in localized production facilities. The shift toward co-processed excipients is expected to reduce formulation time by 19% and improve drug stability by 23%.

New Product Development

Innovation in excipients focuses on functionality, sustainability, and efficiency. Over 230 new formulations were introduced between 2023–2025. Co-processed excipients combining polymer and sugar functionalities achieved 28% better compressibility. Bio-derived polymers increased by 27%, while plant gelatin alternatives rose by 21%. 34% of manufacturers developed water-soluble excipients to replace alcohol-based variants. AI-driven analytics now optimize excipient quality consistency across 1.2 million test samples annually

Five Recent Developments (2023–2025)

• BASF SE launched 10 new polymer excipients for controlled-release drugs in 2024.
• Avantor introduced AI-optimized co-processed excipients, improving compressibility by 25%.
• Roquette expanded its plant-based excipient line, increasing output by 19% in 2024.
• Ashland opened a new R&D facility in Asia to develop sustainable polymers, increasing regional capacity by 22%.
• DFE Pharma developed a multifunctional excipient used in 350 drug formulations worldwide.

Report Coverage of Excipients Market

The Excipients Market Report provides detailed coverage of global market structure, segmentation, and performance indicators. It includes data from 1,200 manufacturers and analyzes 12,500 excipient grades across pharmaceutical, nutraceutical, and cosmetic applications. The report examines polymer (37%), sugar (22%), and alcohol (18%) excipient usage patterns. Regional analysis covers North America (39% share), Europe (30%), Asia-Pacific (24%), and the Middle East & Africa (7%). More than 230 new product launches and 41 plant expansions are analyzed. The report also assesses technological advancements, regulatory dynamics, and sustainable product innovations influencing future market strategies.

Excipients Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 5406.22 Million in 2026
Market Size Value By	USD 8479.25 Million by 2035
Growth Rate	CAGR of 5.89% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Polymers Alcohols Sugars Minerals Gelatin By Application : Pharmaceutical Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample